These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25232417)

  • 21. Nocturia and Sleep in Parkinson's Disease.
    Diaconu Ş; Irincu L; Ungureanu L; Țînț D; Falup-Pecurariu C
    J Pers Med; 2023 Jun; 13(7):. PubMed ID: 37511666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-motor symptoms in a Flanders-Belgian population of 215 Parkinson's disease patients as assessed by the Non-Motor Symptoms Questionnaire.
    Crosiers D; Pickut B; Theuns J; Deyn PP; Van Broeckhoven C; Martinez-Martin P; Chaudhuri KR; Cras P
    Am J Neurodegener Dis; 2012; 1(2):160-7. PubMed ID: 23383390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease.
    Lee HM; Koh SB
    J Mov Disord; 2015 May; 8(2):92-7. PubMed ID: 26090081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motor and non-motor features of Parkinson's disease in LRRK2 G2019S carriers versus matched controls.
    Gunzler SA; Riley DE; Chen SG; Tatsuoka CM; Johnson WM; Mieyal JJ; Walter EM; Whitney CM; Feng IJ; Owusu-Dapaah H; Mittal SO; Wilson-Delfosse AL
    J Neurol Sci; 2018 May; 388():203-207. PubMed ID: 29627023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-Motor Symptoms Assessed by Non-Motor Symptoms Questionnaire and Non-Motor Symptoms Scale in Parkinson's Disease in Selected Asian Populations.
    Sauerbier A; Jitkritsadakul O; Titova N; Klingelhoefer L; Tsuboi Y; Carr H; Kumar H; Banerjee R; Erro R; Bhidayasiri R; Schrag A; Zis P; Lim SY; Al-Hashel JY; Kamel WA; Martinez-Martin P; Ray Chaudhuri K
    Neuroepidemiology; 2017; 49(1-2):1-17. PubMed ID: 28803229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-motor symptoms of Parkinson`s disease-insights from genetics.
    Jerčić KG; Blažeković A; Borovečki S; Borovečki F
    J Neural Transm (Vienna); 2024 Nov; 131(11):1277-1284. PubMed ID: 39294309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF Nrf2 and HSPA8 in Parkinson's disease patients with and without LRRK2 gene mutations.
    Loeffler DA; Smith LM; Coffey MP; Aasly JO; LeWitt PA
    J Neural Transm (Vienna); 2016 Mar; 123(3):179-87. PubMed ID: 26526034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in the reduced pteridine contents in the cerebrospinal fluids of LRRK2 mutation carriers and patients with Parkinson's disease.
    Ichinose H; Inoue KI; Arakawa S; Watanabe Y; Kurosaki H; Koshiba S; Hustad E; Takada M; Aasly JO
    J Neural Transm (Vienna); 2018 Jan; 125(1):45-52. PubMed ID: 28864907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of non-motor symptoms in Parkinson's Disease: An underestimated necessity.
    Bostantjopoulou S; Katsarou Z; Karakasis C; Peitsidou E; Milioni D; Rossopoulos N
    Hippokratia; 2013 Jul; 17(3):214-9. PubMed ID: 24470730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and duration of non-motor symptoms in prodromal Parkinson's disease.
    Durcan R; Wiblin L; Lawson RA; Khoo TK; Yarnall AJ; Duncan GW; Brooks DJ; Pavese N; Burn DJ;
    Eur J Neurol; 2019 Jul; 26(7):979-985. PubMed ID: 30706593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Both Motor and Non-Motor Fluctuations Matter in the Clinical Management of Patients with Parkinson's Disease: An Exploratory Study.
    Carpi M; Pierantozzi M; Cofano S; Fernandes M; Cerroni R; De Cillis F; Mercuri NB; Stefani A; Liguori C
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of non-motor symptoms and their impact on quality of life in patients with Parkinson's disease, Isfahan, Iran.
    Salari M; Chitsaz A; Etemadifar M; Najafi MR; Mirmosayyeb O; Bemanalizadeh M; Panahi F; Mirzajani H
    Iran J Neurol; 2017 Jul; 16(3):118-124. PubMed ID: 29114366
    [No Abstract]   [Full Text] [Related]  

  • 34. Profiling Non-motor Symptoms in Monogenic Parkinson's Disease.
    Liu X; Le W
    Front Aging Neurosci; 2020; 12():591183. PubMed ID: 33192488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-motor symptoms in Thai patients with Parkinson's disease studied at Phramongkutklao Hospital.
    Vongvaivanich K; Nidhinandana S; Udommongkol C; Chairungsaris P; Chinvarun Y; Wongmek W; Suphakasem S; Suwantamee J; Sithinamsuwan P
    J Med Assoc Thai; 2014 Feb; 97 Suppl 2():S159-67. PubMed ID: 25518190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of Nonmotor Symptoms in Parkinson's Disease by Sex and Motor Laterality.
    Kurlawala Z; Shadowen PH; McMillan JD; Beverly LJ; Friedland RP
    Parkinsons Dis; 2021; 2021():8898887. PubMed ID: 33868631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory dysfunction in sporadic Parkinson's Disease and LRRK2 carriers.
    Johansen KK; Warø BJ; Aasly JO
    Acta Neurol Scand; 2014 May; 129(5):300-6. PubMed ID: 23937295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LRRK2 G2019S Induces Anxiety/Depression-like Behavior before the Onset of Motor Dysfunction with 5-HT
    Lim J; Bang Y; Choi JH; Han A; Kwon MS; Liu KH; Choi HJ
    J Neurosci; 2018 Feb; 38(7):1611-1621. PubMed ID: 29305532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diapocynin prevents early Parkinson's disease symptoms in the leucine-rich repeat kinase 2 (LRRK2R¹⁴⁴¹G) transgenic mouse.
    Dranka BP; Gifford A; Ghosh A; Zielonka J; Joseph J; Kanthasamy AG; Kalyanaraman B
    Neurosci Lett; 2013 Aug; 549():57-62. PubMed ID: 23721786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.